Schrödinger, Inc. (SDGR)
收市後：
- InvestorPlace
7 Pharma Stocks Harnessing AI Brainpower for Big Breakthroughs
It’s no secret that artificial intelligence (AI) promises to transform every industry and sector, pharma included. But how do those companies plan to leverage AI, and what will it do for their stocks? The answers, of course, are as varied as the companies leveraging AI. Many will leverage AI for the process of drug discovery. AI is much more efficient at identifying compounds with potential efficacy for a given disease or disorder. Others are utilizing AI to improve the development process for v
- Motley Fool
What's the Difference Between Biotech Stocks and TechBio Stocks?
A few enterprising businesses are marketing themselves differently.
- Insider Monkey
Schrödinger, Inc. (NASDAQ:SDGR) Q1 2024 Earnings Call Transcript
Schrödinger, Inc. (NASDAQ:SDGR) Q1 2024 Earnings Call Transcript May 1, 2024 Schrödinger, Inc. reports earnings inline with expectations. Reported EPS is $-0.76 EPS, expectations were $-0.76. SDGR isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Welcome to Schrödinger’s Conference Call […]
